Ligand Pharmaceuticals' GAAP net income for 9M 2021 was $62.554 million, compared to a loss of $8.746 million in the previous year. Revenue increased 75.8% to $204.66 million from $116.429 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept